FDA pilots program for more facilities inspections

The FDA has launched a pilot program using artificial intelligence to identify low-risk medical device and manufacturing facilities for streamlined one-day inspectional assessments, both domestically and internationally. FDA Commissioner Marty Makary announced the initiative at the Food and Drug Law Institute Annual Conference, aiming to make inspections more targeted and efficient.